Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Aiforia

Helsinki Healthtech Startup Aiforia Secures €20 Million in EIB Venture Debt for AI Diagnostics Expansion

August 3, 2026 by Lars Eriksson

Helsinki‑based AI life‑science startup Aiforia obtained €20 million of venture debt from the European Investment Bank, backed by the EU InvestEU programme, to speed up its AI‑driven cancer diagnostic platform and grow its global commercial presence.

Categories Funding Tags €20M–€100M, Aiforia, Finland, Growth, Healthtech Leave a comment
Browse by Country

Latest

Polish Fintech Startup Nu Delta Shares Lessons From 16-Month Banking DealNov 9, 2026
French Nuclear Startup Calogena Secures €40 Million EU Grant for District Heating ProjectNov 9, 2026
Polish smart home camera maker OMVI unveils multi-function security cameras with advanced tracking capabilitiesNov 9, 2026
Monzo Eyes £500 Million Funding Round in Bid to Expand Digital Banking ReachNov 9, 2026
Danish Cemetery Management Platform Memora Secures €1.7M Series A to Digitise European OperationsNov 9, 2026

EU Markets

Europe's Financial Pulse: AI Bets, Rate Signals, and What Founders Need to Know This WeekNov 6, 2026
European Markets Flash Caution Signals: What This Week's Financial Turbulence Means for Startup FoundersOct 30, 2026
European Startups, Brace Yourselves: Rate Pressures, AI Disruption, and a €550M Legal Tech Unicorn Define This Week's Financial LandscapeOct 23, 2026
French Debt Fears, AI Tailwinds, and a New Unicorn: What Europe's Financial Markets Mean for Your Startup This WeekOct 16, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.